Minimally invasive, indirect corneal neurotization using an ipsilateral sural nerve graft for early neurotrophic keratopathy.
Corneal neurotization
Corneal sensation
In vivo confocal microscopy
Neurotrophic keratopathy
Sural nerve autograft
Journal
American journal of ophthalmology case reports
ISSN: 2451-9936
Titre abrégé: Am J Ophthalmol Case Rep
Pays: United States
ID NLM: 101679941
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
24
06
2021
revised:
10
05
2022
accepted:
11
05
2022
entrez:
6
6
2022
pubmed:
7
6
2022
medline:
7
6
2022
Statut:
epublish
Résumé
Neurotrophic keratopathy is a degenerative disease characterized by damage to the corneal nerves leading to corneal hypoesthesia and anaesthesia. The resultant progressive visual deterioration is refractory to existing conventional treatment options. Corneal neurotization is a novel and effective surgical procedure that directly targets the underlying pathology of nerve loss by stimulating new corneal nerve growth. This study reports the outcomes and the pre- and postoperative in vivo confocal microscopy findings of the first published Australian case of indirect, minimally invasive, corneal neurotization using an ipsilateral sural nerve autograft. An 11-year-old boy developed corneal hypoesthesia in the left eye following surgical debulking of a cerebellopontine angle arachnoid cyst. He was diagnosed with Mackie Stage 1 neurotrophic keratopathy. Due to his hypoesthesia, he had developed recurrent microbial keratitis and corneal ulceration secondary to foreign bodies sustained during contact sports. At presentation, he reported photophobia and dry eye symptoms, corrected-distance visual acuity was 6/18, Cochet-Bonnet aesthesiometer demonstrated reduced corneal sensation (5-15mm), Schirmer's I test was 15mm, and in vivo confocal microscopy showed a complete absence of a subepithelial corneal plexus. He underwent indirect, minimally invasive, corneal neurotization using the ipsilateral supratrochlear nerve and a sural nerve autograft. Subjective improvement in corneal sensation was noticed by the patient at 2 months. Objective improvement, measured on Cochet-Bonnet aesthesiometer, was first observed at 6 months with steady stepwise improvement to 20-35mm at 21 months. Importantly, due to the increase in corneal sensation, the patient did not develop any further corneal complications. At 12 months, dry eye symptoms resolved and Schirmer's I test improved to 30mm. At 15 months, corrected-distance visual acuity improved to 6/5 and in vivo confocal microscopy demonstrated evidence of corneal reinnervation with nerves running through the subepithelial space surrounded by healthy and active keratocytes. Corneal neurotization represents an exciting development in the armamentarium for the treatment of neurotrophic keratopathy and can be considered for younger patients with early-stage disease.
Identifiants
pubmed: 35664449
doi: 10.1016/j.ajoc.2022.101585
pii: S2451-9936(22)00331-0
pmc: PMC9156881
doi:
Types de publication
Case Reports
Langues
eng
Pagination
101585Informations de copyright
© 2022 The Authors.
Références
Cornea. 2018 Jan;37(1):109-112
pubmed: 29053558
J Craniofac Surg. 2017 Jul;28(5):1167-1170
pubmed: 28570404
Semin Ophthalmol. 2019;34(7-8):473-487
pubmed: 31370735
Cornea. 2018 May;37(5):641-646
pubmed: 29373338
Ophthalmic Plast Reconstr Surg. 2020 Sep/Oct;36(5):431-437
pubmed: 31923091
Prog Retin Eye Res. 2018 Sep;66:107-131
pubmed: 29698813
Am J Ophthalmol. 2020 Dec;220:203-214
pubmed: 32659280
Br J Ophthalmol. 2019 Jan;103(1):26-35
pubmed: 30242061
JAMA Ophthalmol. 2014 Nov;132(11):1289-95
pubmed: 25010775
Br J Ophthalmol. 2019 Dec;103(12):1724-1731
pubmed: 30770356
Ocul Surf. 2021 Apr;20:163-172
pubmed: 33647470
Plast Reconstr Surg. 2009 Jan;123(1):112-120
pubmed: 19116544